Delivery Order SPE2DB22D3501-SPE2DB23FWM49
Award Date 7/21/23
Potential Completion Date 7/24/23
Potential Value $62
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a delivery order valued at $61,880 by the Defense Logistics Agency to provide 500 mg/50 ml vials of Leucovorin Calcium. The firm fixed price order is for product delivery by June 29, 2023 in Conshohocken, Pennsylvania and was issued under the DLA's Prime Vendor program, which centrally manages pharmaceutical distribution for various Department of Defense components. No subcontractors or...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $59,150 delivery order by the Defense Logistics Agency to provide 500mg vials of Leucovorin Calcium. The firm fixed price order is associated with DLA's prime vendor program and will be performed in Conshohocken, Pennsylvania over a one day period concluding on June 29, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency utilizes various contracting...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $102,480 delivery order by the Defense Logistics Agency to provide 500 mg/50 ml vials of Leucovorin Calcium. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania within a one day period beginning on August 8, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency routinely issues delivery orders against...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a delivery order valued at $247.52 by the Defense Logistics Agency to provide 500 mg/50 ml vials of Leucovorin Calcium. The firm fixed price order is for a single day of performance in Conshohocken, Pennsylvania on August 7-8, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues such orders under its Prime Vendor program to support...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $102,480 delivery order by the Defense Logistics Agency to provide 500 mg/50 ml vials of Leucovorin Calcium. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania within a one day period beginning on August 8, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency routinely issues delivery orders against...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $62,000 firm fixed price delivery order by the Defense Logistics Agency to provide 500 milligram/50 milliliter vials of Leucovorin Calcium. The single day contract has a period of performance from August 1-2, 2023 and will be carried out in Conshohocken, Pennsylvania. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues such delivery...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $61,880 delivery order against the Defense Logistics Agency's Prime Vendor program. The firm fixed price order is to provide 4561368001 LEUCOVORIN CAL 500 MG/50 ML VL 50ML to DLA from Amerisourcebergen's facility in Conshohocken, Pennsylvania. Performance will take place from June 28 to June 29, 2023. As the DLA manages the Department of Defense's supply chain, this order will deliver an...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $40,600 firm fixed price delivery order by the Defense Logistics Agency to provide 100 mg vials of the chemotherapy drug Leucovorin Calcium. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 1st to August 2nd, 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department of...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $62,000 firm fixed price delivery order by the Defense Logistics Agency to provide 500 mg/50 ml vials of Leucovorin Calcium. The single delivery order is for product to be shipped from Amerisourcebergen's facility in Conshohocken, Pennsylvania to an unknown destination by June 29, 2023. No additional details were provided on the original solicitation or whether this delivery order is...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $113,080 delivery order by the Defense Logistics Agency to provide 500 mg/50 ml vials of Leucovorin Calcium. The firm fixed price order is for product delivery by June 29, 2023 with performance taking place in Conshohocken, Pennsylvania. No set aside designation or subcontracting details were provided. The Defense Logistics Agency utilizes contracts like this to efficiently procure...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FWM49Delivery Order
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at approximately $62,000 by the Defense Logistics Agency to provide Leucovorin Calcium 500 mg/50 ml vials. The firm fixed price order is for product delivery by July 24, 2023 to a location in Conshohocken, Pennsylvania and was issued under the DLA's Prime Vendor program, which centrally manages pharmaceutical distribution for various Department of Defense components. No subcontractors or set aside designations were indicated. This order supports the DLA's provisioning of pharmaceuticals to military treatment facilities and appears consistent with the agency's role in maintaining medical readiness for the armed forces.
Generated 12/17/23, 7:47 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $62 | 7/21/23 |